Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01190904 · ClinicalTrials.gov registry record
Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes
A clinical trial, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- 568
- Enrollment target
NCT01190904: Completed study, sponsored by Icahn School of Medicine at Mount Sinai.
NCT01190904 is a clinical trial that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 568 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01190904 has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- 568 participants
- Enrollment target
Study Summary
The purpose of this study is to find out if androgen deficiency (low levels of testosterone, a male hormone produced by the sex glands) and erectile dysfunction (sexual dysfunction) will predict over time the development of a heart attack, stroke, or death in men with Diabetes Mellitus who have angiographically proven coronary artery disease (CAD) (≥50%) with or without percutaneous coronary intervention (PCI). A substudy aims to show the different factors and processes that may show a relationship between sexual function and levels of androgen in the body to heart disease.
Primary Outcome
The primary outcome is time to composite outcome of all-cause mortality, MI or stroke.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 568 participants |
| Start Date | 2010-01 |
| Est. Completion | 2016-07 |
What the finished NCT01190904 record still lists
NCT01190904 is an observational study that tracks outcomes without assigning an intervention. The registered 568 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT01190904 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01190904 about?
NCT01190904 is a clinical study titled "Hormones and Sexual Function Predict Outcomes in Revascularized Men With Diabetes". The purpose of this study is to find out if androgen deficiency (low levels of testosterone, a male hormone produced by the sex glands) and erectile dysfunction (sexual dysfunction) will predict over time the development of a heart attack, stroke, or death in men with Diabetes Mellitus who have angi...
What is the current status of trial NCT01190904?
This trial is currently completed. The enrollment target is 568 participants. The study started on 2010-01. Estimated completion is 2016-07.
Who is sponsoring clinical trial NCT01190904?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05472441 · 568 participants · NA
Linking Education, Produce Provision, and Community Referrals to Improve Diabetes Care (LINK)
- NCT05000645 · 570 participants · NA
Grocery Delivery and Healthy Weight Gain Among Low-income Pregnant Young Women
- NCT06239844 · 570 participants · NA
Navigating Together for Equitable Asthma Management for Children in Families Who Communicate in Language Other Than English
- NCT06701903 · 570 participants · Phase 2
Study of ITI-1284 as Monotherapy Treatment in Patients With Generalized Anxiety Disorder
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia